Skip to main content
. Author manuscript; available in PMC: 2009 Feb 23.
Published in final edited form as: Cancer Biother Radiopharm. 2006 Apr;21(2):155–166. doi: 10.1089/cbr.2006.21.155

Figure 2.

Figure 2

Planar nuclear scintigraph of the distribution of 177Lu-DOTA-8AOC-BBN(7-14)NH2 obtained 48 hours post radiopharmaceutical administration in a PC-3 human prostate tumor xenografted SCID mouse. The areas of highest focal intensity of 177Lu-DOTA-8AOC-BBN(7-14)NH2 correspond to PC-3 xenograft location.